Navigation Links
Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention
Date:8/3/2009

Paper is First in a Series Based on Presentations from Cervical Cancer Prevention Forum Hosted by SGO

CHICAGO, Aug. 3 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) has published the first in a series of four papers on a variety of cervical cancer issues and topics that were the focus of its Forum "The Future Strategies for Cervical Cancer Prevention: What Do We Need to Do Now to Prepare," held last September in Chicago, Illinois. The paper, entitled "The Impact of Human Papillomavirus Vaccination on Cervical Cancer Prevention Efforts," is featured in the August, 2009 issue of Gynecologic Oncology. It includes data relevant to HPV natural history as well as excerpts from Forum discussions regarding the limits of current screening, the impact that eliminating HPV 16/18 through vaccination may have on rates of cervical precancer and cervical cancer screening, strategies to measure vaccine uptake and obstacles surrounding separate screening for vaccinated women.

In particular, the manuscript addresses the obstacles to cervical cancer screening and prevention arising from vaccination against HPV types 16 and 18. It suggests potential new directions for screening now that HPV vaccination has been adopted. Dr. Stewart Massad, the paper's lead author and a member of the SGO Forum's Organizational Committee, concludes that until population-based data on the performance of cytology, HPV testing and alternate screening or triage interventions become available, modification of current screening guidelines would be premature.

"The section of the Forum that this paper addresses focused on identifying current problems that restrict the utility of screening with an HPV test rather than a Pap test," explains Dr. Massad. "The research shared and discussed during this section of the Forum indicates that if administered prior to first exposure, the vaccine can prevent up to 70 percent of cervical cancers. But many women are being vaccinated after exposure and modifying screening places them at increased risk for cancer. The information shared in this session and captured in this manuscript is an excellent resource, both as a snapshot of the current knowledge surrounding the impact and effectiveness of the HPV vaccine, and as a touchstone for areas where further research and investigation are needed to identify modifications in screening guidelines and intervention techniques."

"The Future Strategies of Cervical Cancer Prevention: What Do We Need to Do Now to Prepare," Forum focused on cervical cancer in the HPV vaccine era and was attended by more than 50 thought-leaders and cervical cancer experts from clinical, medical, epidemiology, regulatory and public health backgrounds. Sessions throughout the day and a half meeting explored issues and concerns of public policy, clinical and cost effective issues surrounding the future of cervical cancer prevention as the HPV vaccination is more widely implemented across the country.

In addition to "The Impact of Human Papillomavirus Vaccination on Cervical Cancer Prevention Efforts," manuscript, subsequent papers are being developed for publication on additional topics discussed at the Forum including:

  • Current and future state of HPV typing of the vaccinated population
  • Barriers of HPV vaccination in high risk populations
  • Policies influencing HPV vaccination and screening

"The information garnered from this meeting and shared through this series of white papers will serve as an invaluable tool to our colleagues who, like us, share our vision of eradicating women's cancers," explains David Mutch, M.D., SGO President. "As a premier source of education in gynecologic oncology, our Society is committed to providing the most current data and late-breaking research studies for the good of our subspecialty, our peers, and most importantly, our patients."

ABOUT SGO

The SGO is a national medical specialty organization of physicians who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge which will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women's health care, oncology and related fields. The Society's membership, totaling more than 1230, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists and pathologists. SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care. More information on the SGO can be found at www.sgo.org.

    For more information please contact: Susan Morris Society of Gynecologic Oncologists
    Phone: 312/235-4060 x 244
    Fax: 312/235-4059
    E-mail: susan.morris@sgo.org


'/>"/>
SOURCE Society of Gynecologic Oncologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
5. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
6. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
7. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... -- Dutch surgeons have launched a ground-breaking medical app ... treat patients on a global scale. Medical professionals from ... and the US have already signed up for the ... a totally secure environment. Education  "Imagine a ... with a surgeon at Harvard to treat a bomb victim via ...
(Date:5/23/2016)... May 23, 2016 According ... Equipment Market by Product (Wheelchair, Scooters, Medical Beds, ... Care, Critical Care, Wound), Accessories (Lifting, Transfer) & ... 2021", published by MarketsandMarkets, the patient handling equipment ... by 2021 at a CAGR of 10.5% during ...
(Date:5/23/2016)... 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today ... programs. The hands-on learning experience is a 12-week summer ... Fellowship and Internship programs bring ... and interns are provided optional housing free of charge ... at the Riverfront Residence Hall to foster communication and ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... 2016 , ... According to the Webster’s dictionary, a hippie is defined as ... one company is going against the norm with a line of all-natural skincare that’s ... the green space is proud to announce its latest retail partnership with the Vitamin ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... weekend to host their second pop-up shop for three consecutive weekends. The pop-up ... to the Santa Barbara community, a community full of women who appreciate the ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... been hired as FluidEdge’s Vice President of Business Intelligence and Informatics, effective immediately. ... has demonstrated success leading teams as a healthcare business and financial strategist for ...
(Date:5/25/2016)... ... ... The United States Food and Drug Administration (FDA) has now cleared Capillus® laser ... the company is the first and only manufacturer of low level laser therapy (LLLT) ... , “This new level of clearance substantiates what many physicians have experienced firsthand ...
(Date:5/25/2016)... Pembroke Pines, FL (PRWEB) , ... ... ... Hospital West has received the American Heart Association/American Stroke Association's Get With ... Plus designation. , This achievement, a second for Memorial Healthcare System, ...
Breaking Medicine News(10 mins):